Blood Irradiator Market –- Insights
Blood irradiators are used to in the treatment of graft-versus-host disease (GVHD) and in various medical and research applications such as preparing blood for transfusion and cancer research. These irradiators irradiate blood and blood components in order to prevent the proliferation of T lymphocytes that can inhibit the immune response, which otherwise may cause GVHD. Transfusion recipients at risk for GVHD such as fetuses receiving intrauterine transfusions, patients undergoing hematopoietic transplantation, and individuals receiving platelets are required to undergo irradiation procedure. Blood irradiation plays a major role in surgeries, cancer treatment, chronic illnesses, and traumatic injuries.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/1972
Increasing focus on decreasing the cases of GVHD is expected to boost growth of the market
Blood irradiator aids in preventing from GVHD, a rare but serious complication of transfusion complication of blood transfusion. According to the Royal Children’s Hospital Melbourne, transfusion-associated GVHD occurs when donor lymphocytes from transfused blood engraft in the recipient, thereby leading to hepatitis, diarrhea, and pancytopenia with clinical features of fever and skin rash. Moreover, the condition is fatal in over 90% of cases.
Major government and non-profit organizations are focused on offering financial aid for R&D of blood irradiators, which is expected to propel growth of the global blood irradiator market. For instance, in 2014, Stellarray, Inc., a developer of novel x-ray sources, was awarded the US$ 1.1 Mn grant by the Department of Energy to develop and commercialize new generation irradiators for ensuring the safety of blood transfusions by replacing cesium 137, which is identified as a national security hazard. Moreover, the Advancing Transfusion Cellular Therapies Worldwide (AABB) works in collaboration with the Food and Drug Administration (FDA) to ensure appropriate irradiation guidance and regulations for blood products, thereby favoring the blood irradiators market by maintaining security and compliance to limit the use of radioactive irradiators.
However, high cost of the irradiators and lack of awareness among population regarding uses and advantages of irradiators is expected to hamper growth of the market. For instance, according to the survey by College of American Pathologists, 2017, the cost of X-ray irradiators is around US$ 250,000 to US$ 300,000, with annual service contract accounting for US$ 15,000 to US$ 20,000.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1972
North America is expected to account for the largest market share
The market in North America is expected to account for the largest market share over the forecast period. This is attributed to increasing product development. For instance, in September 2017, Typenex Medical, launched Rad-Control, a new irradiation indicator tag technology, in the blood banks and blood centers in the U.S. and Canada. Rad-control ensures that blood component has received irradiation, thereby preventing life threatening TA-GvHD.
Moreover, increasing adoption of X-ray irradiators is also expected to propel growth of the market. For instance, in 2017, the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) partnered with the New York City Department of Health and Mental Hygiene (DOHMH) and the Nuclear Threat Initiative (NTI) to replace the radioactive irradiators with the safer X-ray alternatives. High prevalence of sickle cell disease has led to increasing demand for blood transfusion, thereby contributing to the market growth in North America. For instance, according to the American National Red Cross, sickle cell disease affects 90,000 to 100,000 people in the U.S. and about 1,000 infants are born with the disease, annually. Moreover, according to the American Cancer Society, about 1.7 million people are expected to be diagnosed with cancer in 2017. Such people require blood during chemotherapy.
Increasing use of blood irradiators in medical settings to prevent and control the transmission of TA-GVHD is expected to boost growth of the market in North America. For instance, according to the Department of Health and Human Services, 2013, around 500 blood irradiators irradiated around 2 million blood units in 2013.
Major players operating in the global blood irradiator market are focused on adopting collaboration strategies to enhance their market share. For instance, Charter Medical collaborated with RadTag Technologies to distribute the RadTag blood irradiator indicators in the U.S.
Key players operating in the global blood irradiator market include Typenex Medical, Gamma-Service Medical GmbH, Rad Source Technologies, Sukosol Group, Cegelec NDT-PES, and Best Theratronics, Ltd.
To get detailed table of content (ToC), please click: https://www.coherentmarketinsights.com/ongoing-insight/toc/1972
Blood Irradiator Market – Market Taxonomy
On the basis of product type, the global blood irradiator market is segmented into:
- X-ray Irradiators
- Gamma-ray Irradiators
On the basis of end-user, the global blood irradiator market is segmented into:
- Research Institutions
- Blood Banks
On the basis of region, the global blood irradiator market is segmented into:
- North America
- Latin America
- Asia Pacific
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027